Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products ・This expansion aims to ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Aurora’s (NASDAQ:ACB) medical cannabis added C$68.1M to the company’s topline with ~51% YoY while its plant propagation business generated C$8.9M in net revenue with ~22% YoY rise, and ACB’s ...

Shares of Aurora Cannabis Inc. ACB shed 2.04% to $4.33 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to ...

Analysts raised concerns about potential pricing impacts from increased competition in global medical cannabis markets. Martin emphasized Aurora’s competitive advantages, including regulatory ...